跳至主要内容
临床试验/ISRCTN13184358
ISRCTN13184358已完成4 期

The role of endothelial progenitor and circulating endothelial cells in cardiovascular risk of patients with sub clinical hyperthyroidism

Tan Tock Seng Hospital0 个研究点目标入组 40 人开始时间: 2020年3月3日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34823331/ (added 03/12/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Diagnosis of subclinical hyperthyroidism confirmed at least on two occasions (low serum TSH with normal FT4) and one normal FT3 levels within three months prior to the recruitment
  • 2. Aged 21-85 years
  • 3. Written informed consent

排除标准

  • 1. Sick euthyroid syndrome
  • 2. Recent radioiodine therapy (within 1 year of screening visit)
  • 3. Pregnant or breastfeeding patients
  • 4. Acute medical illnesses such as infections and active cancer

研究者

发起方
Tan Tock Seng Hospital

相似试验

Investigating the risk of heart and blood vessel... | 临床试验